Determine the Incidence of Long QT Amongst a Large Cohort of Subjects Diagnosed With Unilateral or Bilateral Sensorineural Hearing Loss.
Long QT & Hearing Loss Prospective Study Registry
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
The purpose of this study is to determine the true incidence of long QT (LQT) amongst a large cohort of subjects diagnosed with unilateral (right/left) or bilateral sensorineural hearing loss.
The goal of this study is to answer the following questions:
- What is the incidence of an abnormal ECG (QTc > 450 msec) in neonates greater than a week of age with either unilateral or bilateral Sensorineural hearing loss?
- What percentage of neonates greater than one week of age with either bilateral or unilateral sensorineural hearing loss and an abnormal ECG have an identifiable genetic mutation?
- What is the incidence of an abnormal genetic mutation consistent with long QT regardless of the ECG in neonates with bilateral sensorineural hearing loss?
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Locations
-
-
Alaska
-
Anchorage, Alaska, United States, 99508
- Jack Jacob
-
-
Arizona
-
Phoenix, Arizona, United States, 85013
- St. Joseph's Hospital & Medical Center
-
Phoenix, Arizona, United States, 85006
- Banner Good Samaritan Hospital
-
-
Connecticut
-
Waterford, Connecticut, United States, 06320
- Lawrence and Memorial Hospital
-
-
Illinois
-
Rockford, Illinois, United States, 61104
- Swedish American Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73120
- Hearts for Hearing
-
-
Texas
-
Austin, Texas, United States, 78723
- Dell Children's Medical Center
-
Austin, Texas, United States, 78756
- Child Cardiology Associates
-
San Antonio, Texas, United States, 78251
- Christus Santa Rosa Westover Hills
-
San Antonio, Texas, United States, 8207
- Children's Hospital of San Antonio
-
-
Virginia
-
Alexandria, Virginia, United States, 22304
- Alexandria Hospital- Inova Health System
-
Fairfax, Virginia, United States, 22031
- Pediatrix Audiology Services
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All newborns who demonstrate a refer in one or both ears on a routine newborn hearing screen
- Documentation of informed consent
- Inborn
- Ability to perform an ABR (auditory brainstem response screen technology) screening test
- No major anomalies
- Subjects' parents willing to provide follow-up data on their child
Exclusion Criteria:
- Newborns with a syndromic cause of hearing loss
- Parents unwilling to provide follow-up data
- Major congenital anomalies
- Major medical problem or conditions. (i.e., hypoxic ischemic encephalopathy (HIE), persistent pulmonary hypertension neonate (PPHN), meconium aspiration, etc.)
- Congenital cytomegalovirus (CMV)
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The incidence of an abnormal ECG (QTc > 450) in neonates greater than a week of age with either unilateral or bilateral sensorineural hearing loss
Time Frame: 6 months
|
ECG results to determine QTc length
|
6 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
In neonates > 1 week of age with either bilateral or unilateral sensorineural hearing loss and an abnormal ECG, percentage have an identifiable genetic mutation
Time Frame: One year
|
Audiology diagnostic results
|
One year
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Mitchell Cohen, MD, Pediatrix
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Heart Diseases
- Cardiovascular Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Congenital Abnormalities
- Otorhinolaryngologic Diseases
- Ear Diseases
- Arrhythmias, Cardiac
- Cardiac Conduction System Disease
- Sensation Disorders
- Heart Defects, Congenital
- Cardiovascular Abnormalities
- Hearing Disorders
- Hearing Loss
- Deafness
- Hearing Loss, Sensorineural
- Long QT Syndrome
Other Study ID Numbers
Other Study ID Numbers
- PDX-001-13
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.